Abamectin


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:12798765IVR1.19 mg/kg/day 1.19 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR1.19 mg/kg/day 1.19 mg/kg/dayIncreased testis weightsReproductive endocrine-mediated perturbations
IVR1.19 mg/kg/day 1.19 mg/kg/dayAffects fertilityReproductive endocrine-mediated perturbations
IVR1.19 mg/kg/day 1.19 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR1.19 mg/kg/day 1.19 mg/kg/dayAffects litter sizeReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayIncreased FSH levelsReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayIncreased testis weightsReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayAffects litter sizeReproductive endocrine-mediated perturbations
IVR2.13 mg/kg/day 2.13 mg/kg/dayAffects fertilityReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayAffects fertilityReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayAffects litter sizeReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayIncreased testis weightsReproductive endocrine-mediated perturbations
IVR1.87 mg/kg/day 1.87 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.